Search fresh public links, source activity, and ready-to-use post angles for Covid-19 Vaccine.
Fresh curated links around COVID-19 Vaccine are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
A new wave of COVID-19 is sweeping the country, with cases on the rise in nearly every state. As of Aug. 19, the U.S. Centers for Disease Co... read more...
The shots have been approved for people 65 and older, and for younger people with underlying conditions. Others may be able to get them off label.
Updated COVID-19 vaccines targeting the XFG variant have been approved by the FDA for older adults and others at high risk.
Leading health organizations joined forces to issue the recommendations, citing a lack of strong guidance from the federal government.
Getting ready for the fall and winter respiratory virus season can raise questions about immunizations you might need, when to get them and how to keep your family safe.
University Hospitals and Celloram are advancing Protexi, a platform that redirects antiviral immune memory from COVID-19 toward fighting tumors, with sarcoma trials planned.
Exactly who should get one or all of these vaccines, and when?
The new vaccine is approved for adults 50 and older, with availability expected during the 2026–2027 respiratory virus season
The Food and Drug Administration recently updated 2026-27 COVID-19 vaccines. Here's what to know in Georgia.
(Note: Thank you for supporting businesses like the one presenting a sponsored message below and working with them through the links below which benefits Gateway Pundit. The post D...
By Elise Haulund, Katherine Dillinger, Meg Tirrell, CNN (CNN) — The US Food and Drug Administration on Wednesday approved the United States’ first mRNA-based flu vaccine for adults...
Review of past studies by group led by University of Minnesota finds no new or worsening signs to discourage people from seeking flu, COVID-19, RSV shots this fall and winter.
The Vaccine Integrity Project, in collaboration with the American Medical Association (AMA), today announced the completion of an independent, vaccine evidence review that assess...
FDA approves Moderna's first mRNA flu vaccine for adults 50 and older, but local availability may take time.
Smaller “fractional” doses of COVID-19 booster vaccines may deliver long-lasting immunity while stretching limited supply—an approach that could lower costs and expand access durin...
Moderna and Merck say their personalized mRNA therapy showed positive results in a major Phase 3 trial — potentially changing how America treats one of its deadliest skin cancers.
Leading U.S. medical groups are urging people to get updated flu and COVID-19 vaccinations this fall, banding together Wednesday to issue shot guidelines — and highlight the scienc...
Who should get the vaccine, when to get it and more.
In a somewhat surprise announcement, the Food and Drug Administration (FDA) has approved the first US influenza vaccine built on Moderna's mRNA technology that gave us one of...
The legal team at mctlaw urges Congress to pass the Vaccine Injury Compensation Modernization Act of 2026 (H.R. 9672), which would finally include COVID vaccine injury claims in th...
Research shows the new mRNA flu vaccine technology provides 27% more coverage against influenza than traditional flu vaccines.
Recommendations aim to mitigate severe illness and protect vulnerable populations while addressing the increasing case numbers of COVID-19, influenza, and RSV.
Por Elise Haulund, Katherine Dillinger y Meg Tirrell, CNN La Administración de Alimentos y Medicamentos (FDA, por sus siglas en inglés) aprobó este miércoles la primera vacuna cont...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.